share_log

Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

Biodexa Pharmaceuticals | 6-K：外國發行人報告（業績相關）
美股SEC公告 ·  05/16 05:01
牛牛AI助理已提取核心訊息
Biodexa Pharmaceuticals PLC has announced the distribution of its Annual Report for the fiscal year ending December 31, 2023, along with the Notice of Annual General Meeting (AGM) to its shareholders. The announcement, made on May 15, 2024, includes the provision of proxy forms for both ordinary shareholders and holders of American Depositary Shares to participate in the upcoming AGM. The meeting is scheduled for June 13, 2024, at the company's registered office in Cardiff, United Kingdom. The documents related to the Annual Report and AGM, including proxy forms, have been attached as exhibits to the company's Form 6-K filing with the United States Securities and Exchange Commission for May 2024.
Biodexa Pharmaceuticals PLC has announced the distribution of its Annual Report for the fiscal year ending December 31, 2023, along with the Notice of Annual General Meeting (AGM) to its shareholders. The announcement, made on May 15, 2024, includes the provision of proxy forms for both ordinary shareholders and holders of American Depositary Shares to participate in the upcoming AGM. The meeting is scheduled for June 13, 2024, at the company's registered office in Cardiff, United Kingdom. The documents related to the Annual Report and AGM, including proxy forms, have been attached as exhibits to the company's Form 6-K filing with the United States Securities and Exchange Commission for May 2024.
Biodexa Pharmicals PLC已宣佈向其股東分發截至2023年12月31日的財政年度的年度報告以及年度股東大會（AGM）通知。該公告於2024年5月15日發佈，包括爲普通股東和美國存托股份持有人提供代理表格，以參加即將舉行的股東周年大會。會議定於2024年6月13日在該公司位於英國加的夫的註冊辦事處舉行。與年度報告和股東周年大會相關的文件，包括委託書，已作爲證物附在公司於2024年5月向美國證券交易委員會提交的6-K表中。
Biodexa Pharmicals PLC已宣佈向其股東分發截至2023年12月31日的財政年度的年度報告以及年度股東大會（AGM）通知。該公告於2024年5月15日發佈，包括爲普通股東和美國存托股份持有人提供代理表格，以參加即將舉行的股東周年大會。會議定於2024年6月13日在該公司位於英國加的夫的註冊辦事處舉行。與年度報告和股東周年大會相關的文件，包括委託書，已作爲證物附在公司於2024年5月向美國證券交易委員會提交的6-K表中。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。